IYH
Equity

iShares U.S. Healthcare ETF

NAV as ofMay 15, 2026
$60.9252 WK: 54.35 - 67.35
1 Day NAV Change as ofMay 15, 2026
Decrease $-0.72(-1.17%)
May 14, 2026
YTD: Decrease -4.99%
Apr 30, 2026
1.32%
Apr 30, 2026
1.31%
Expense Ratio:Fees as stated in the prospectus
0.38%
4 stars
Bronze Medal
NAV as ofMay 15, 2026
$60.9252 WK: 54.35 - 67.35
1 Day NAV Change as ofMay 15, 2026
Decrease $-0.72(-1.17%)
May 14, 2026
YTD: Decrease -4.99%
Apr 30, 2026
1.32%
Apr 30, 2026
1.31%
Expense Ratio:Fees as stated in the prospectus
0.38%
4 stars
Bronze Medal
The iShares U.S. Healthcare ETF seeks to track an index composed of U.S. equities in the healthcare sector. The fund can be used to express a view and gain diversified access to pharmaceuticals, biotechnology, and healthcare equipment companies in the U.S.

Key Facts

Net Assets of Fund
Fund Inception
Exchange
NYSE Arca
Shares Outstanding
46,750,000
as of May 15, 2026
-0.02
as of May 15, 2026
Closing Price
60.91
as of May 15, 2026
0.02%
as of May 15, 2026
Asset Class
Equity
Bloomberg Index Ticker
RIYHCTR
Quarterly
CUSIP
464287762
532,452.00
as of May 15, 2026
504,529.00
as of May 15, 2026

Portfolio Characteristics

13.90%
as of Apr 30, 2026
4.37
as of May 14, 2026
0.54
as of Apr 30, 2026
25.60
as of May 14, 2026

This information must be preceded or accompanied by a current prospectus. For standardized performance, please see the Performance section.

More Funds to Consider

IXJ
iShares Global Healthcare ETFView IXJ
IHE
iShares U.S. Pharmaceuticals ETFView IHE

Holdings

Holdings are subject to change.


The values shown for “market value,” “weight,” and “notional value” (the “calculated values”) are based off of a price provided by a third-party pricing vendor for the portfolio holding and do not reflect the impact of systematic fair valuation (“the vendor price”). The vendor price is not necessarily the price at which the Fund values the portfolio holding for the purposes of determining its net asset value (the “valuation price”). Holdings data shown reflects the investment book of record, which may differ from the accounting book of record used for the purposes of determining the Net Assets of the Fund. Notional value represents the portfolio's exposures based on the economic value of investments and options are delta-adjusted. Additionally, where applicable, foreign currency exchange rates with respect to the portfolio holdings denominated in non-U.S. currencies for the valuation price will be generally determined as of the close of business on the New York Stock Exchange, whereas for the vendor price will be generally determined as of 4 p.m. London. The calculated values may have been different if the valuation price were to have been used to calculate such values. The vendor price is as of the most recent date for which a price is available and may not necessarily be as of the date shown above.

Please see the “Determination of Net Asset Value” section of each Fund’s prospectus for additional information on the Fund’s valuation policies and procedures.

“Quantity” represents the number of shares, units or contracts of the corresponding security, as applicable per security type.

Exposure Breakdowns

Sector
% of Market Value as of May 14, 2026
Pharmaceuticals36.79%
Biotechnology21.70%
Health Care Equipment16.24%
Managed Health Care9.61%
Life Sciences Tools & Services8.57%
Health Care Services2.42%
Health Care Facilities2.20%
Health Care Distributors0.98%
Health Care Supplies0.88%
Health Care Technology0.48%
Cash and/or Derivatives0.12%

Allocations are subject to change.